Fernando Tricta

2.7k citations

49 papers · 1.7k indexed · h-index 16

Impact in

Genetics top 1%
- Hemoglobinopathies and Related Disorders
Hematology top 1%
- Iron Metabolism and Disorders
- Blood groups and transfusion

Papers in

Genetics 40
- Hemoglobinopathies and Related Disorders 40
- Blood disorders and treatments 12
Hematology 38
- Iron Metabolism and Disorders 26
- Blood groups and transfusion 16
- Acute Myeloid Leukemia Research 2

Co-authors: Antonio Piga Renzo Galanello Vincenzo De Sanctis Amal El‐Beshlawy Alan R. Cohen Michael Spino Mohamed Badr Youssef Al‐Tonbary
Journals: Blood (13 papers)American Journal of Hematology (4 papers)Blood Advances (3 papers)HemaSphere (3 papers)PLoS ONE (2 papers)
Partner nations: United States Egypt Canada

In The Last Decade

Fernando Tricta

46 papers receiving 1.6k citations

Peers

Countries citing papers authored by Fernando Tricta

Since Specialization

Citations

This map shows the geographic impact of Fernando Tricta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Tricta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Tricta more than expected).

Fields of papers citing papers by Fernando Tricta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Tricta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Tricta. The network helps show where Fernando Tricta may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fernando Tricta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fernando Tricta Line = papers co-authored together Fernando Tricta links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Real‐world evidence: Long‐term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years American Journal of Hematology ·Janet L. Kwiatkowski, Alexis A. Thompson, Fernando Tricta, Kiuanne Lobo Metzker, Άννα Βασίλα, Caroline Fradette, Sherif M. Badawy	2024	0
2	Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data Blood Advances ·Sherif M. Badawy, Jan Palmblad, Fernando Tricta, Kiuanne Lobo Metzker, Caroline Fradette, Fortunati Elena, Άννα Βασίλα, Sujit Sheth	2024	3
3	Efficacy and Safety of Combination Therapy with Oral Iron Chelators Deferiprone and Deferasirox in Patients with β-Thalassemia Major: A Systematic Literature Review Blood ·Janet L. Kwiatkowski, Sujit Sheth, Antonis Kattamis, Muhammad Mushonnif Junaidi, Fernando Tricta, Caroline Fradette, R Luzzi, Antonio Piga	2024	0
4	Deferiprone versus deferoxamine for transfusional iron overload in sickle cell disease and other anemias: Pediatric subgroup analysis of the randomized, open‐label FIRST study Pediatric Blood & Cancer ·Mona Hamdy, Amal El‐Beshlawy, Sergio Mercado Z., Julie Kanter, Baba Inusa, Suzan Williams, David Lee, Kiuanne Lobo Metzker, Caroline Fradette, Fernando Tricta, Fatma Soliman Elsayed Ebeid, Janet L. Kwiatkowski, Mohsen Saleh Elalfy	2023	4
5	Efficacy and safety of early‐start deferiprone in infants and young children with transfusion‐dependent beta thalassemia: Evidence for iron shuttling to transferrin in a randomized, double‐blind, placebo‐controlled, clinical trial (START) American Journal of Hematology ·Mohsen Saleh Elalfy, Mona Hamdy, Amira Adly, Fatma Soliman Elsayed Ebeid, Kiuanne Lobo Metzker, Άννα Βασίλα, David Lee, Caroline Fradette, Fernando Tricta	2023	9
6	Analysis of the Risk of Infection Stratified By Absolute Neutrophil Counts during Deferiprone-Associated Severe Neutropenia or Agranulocytosis Blood ·Sherif M. Badawy, Jan Palmblad, Fernando Tricta, Kiuanne Lobo Metzker, Caroline Fradette, Fortunati Elena, Άννα Βασίλα, Sujit Sheth	2023	0
7	Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years Blood Advances ·Mohsen Saleh Elalfy, Mona Hamdy, Amal El‐Beshlawy, Fatma Soliman Elsayed Ebeid, Mohamed Badr, Julie Kanter, Baba Inusa, Amira Adly, Suzan Williams, Yurdanur Kılınç, David D. Lee, Caroline Fradette, Άννα Βασίλα, Kiuanne Lobo Metzker, Fernando Tricta, Janet L. Kwiatkowski	2022	16
8	The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease Annals of Hematology ·Denis Soulières, Арутюнов Григорий Павлович, Caroline Fradette, Άννα Βασίλα, J Ilharco, Fernando Tricta	2022	6
9	Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study Blood Advances ·Janet L. Kwiatkowski, Mona Hamdy, Amal El‐Beshlawy, Fatma Soliman Elsayed Ebeid, Spencer Bass, Abdulrahman Alshehri, Julie Kanter, Baba Inusa, Amira Adly, Suzan Williams, Yurdanur Kılınç, David Lee, Fernando Tricta, Mohsen Saleh Elalfy	2021	33
10	Cardiac iron overload evaluation in thalassaemic patients using T2* magnetic resonance imaging following chelation therapy: a multicentre cross-sectional study Hematology Transfusion and Cell Therapy ·Pablo Evia Salas, Kaiyuan Zheng, Kateryna Zinchenko, Lucila Nassif Kerbauy, Ante Gugić, Laércio Alberto Rosemberg, Sandra Regina Loggetto, Darusman Darusman, Francisco Javier Tébar Parreño, María Flores-López, Aline Andrade Barbosa da Silva, Breno Pannia Espósito, Fernando Tricta, Fernando Pinto Torres, Claudia Ângela Galleni Di Sessa Vellozo, Kleber Yotsumoto Fertrin, Ronaldo Hueb Baroni, Nelson Hamerschlak	2021	4
11	An insight into Indonesian current thalassaemia care and challenges ISBT Science Series ·Pustika Amalia Wahidiyat, L. Astigarraga, 西野仁雄, Iswari Setianingsih, テツジアサオ, Wahyu Nur Firdausy, Robert Rigal, Robert Wang, Fernando Tricta	2020	10
12	Neutropenia in Children Treated with Deferiprone or Deferasirox: A Report of the Largest Randomized Trial of Oral Chelators in Transfusion-Dependent Pediatric Patients Blood ·Fernando Tricta, Mariagrazia Felisi, 蔡二朋, Amal El‐Beshlawy, Hoda Hassab, Antonis Kattamis, Ju-Seung Lee, Giorgio Reggiardo, Yanlv Liu, Michael Spino, Bianca Tempesta, M Osteaux, Adriana Ceci	2019	2
13	Safety of Deferiprone in Individuals with Sickle Cell Disease Blood ·Janet L. Kwiatkowski, Fernando Tricta, Άννα Βασίλα	2017	2
14	Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial PLoS ONE ·Deepti Saxena, Michael Spino, Fernando Tricta, John Connelly, Bernadette Cracchiolo, Axel-Rainer Hanauske, Ashwath Rohit, Michael B. Mathews, Jonathan Karn, Bart Holland, Myung Hee Park, Tsafi Pe’ery, Paul Palumbo, Hartmut M. Hanauske‐Abel	2016	31
15	Cost-utility of chelators in transfusion-dependent β-thalassemia major patients: a review of the pharmacoeconomic literature Expert Review of Pharmacoeconomics & Outcomes Research ·Todd A. Lee, ゆかり安見, Fernando Tricta	2014	4
16	Assessment of Iron Overload in Very Young Children with Limited Thalassemia Care Resources in South China Hemoglobin ·Wing‐Yan Au, Hanny Heni Slany Pereira, Yaroslav Semenov, Débora Moreira Maia RICALDONI, Xin Sun, 和馬堤, A. Meadows, Siwei Dai, Hong‐Ying Gao, Arkadi Kim, Darshana D. Rasalkar, Min Deng, Taswin Kaur, Fernando Tricta, Chiu‐Wing Winnie Chu	2014	7
17	Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection PLoS ONE ·Hartmut M. Hanauske‐Abel, Deepti Saxena, Paul Palumbo, Kavyapriya Renganathan, Augusto Ducati Luchessi, F. Jerry Wiens, Mainul Hoque, Michael Spino, Ashwath Rohit, Debra S. Heller, Sukhwinder Singh, Myung Hee Park, Bernadette Cracchiolo, Fernando Tricta, John Connelly, Anthony Popowicz, Richard A. Cone, Bart Holland, Tsafi Pe’ery, Michael B. Mathews	2013	33
18	The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients British Journal of Haematology ·Adriana Ceci, Paola Baiardi, Mariagrazia Felisi, Maria Domenica Cappellini, V. Carnelli, Vincenzo De Sanctis, Renzo Galanello, Aurelio Maggio, Giuseppe Masera, Antonio Piga, Francesco Schettini, Ingo Reich, Fernando Tricta	2002	174
19	Multifocal Pseudoaneurysmal Bone Cysts in Sickle Cell Disease Orthopedics ·Sung Soo Kim, Fernando Tricta, David G. Mohler	2001	1
20	A Multi‐Center Safety Trial of the Oral Iron Chelator Deferiprone Annals of the New York Academy of Sciences ·Alan R. Cohen, Frederick J. Larke, Antonio Piga, C Vullo, Fernando Tricta	1998	29

About Fernando Tricta

Fernando Tricta is a scholar working on Genetics, Hematology, Pediatrics, Perinatology and Child Health, Genetics and Virology, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (40 papers), Iron Metabolism and Disorders (26 papers), Blood groups and transfusion (16 papers), Blood disorders and treatments (12 papers), Pharmacological Effects and Toxicity Studies (11 papers), Neutropenia and Cancer Infections (3 papers), Folate and B Vitamins Research (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Genetics (917 citations), Hematology (876 citations), Pediatrics, Perinatology and Child Health (301 citations), Nutrition and Dietetics (208 citations) and Neurology (169 citations). Fernando Tricta has collaborated with scholars based in United States, Egypt and Canada. Frequent co-authors include Antonio Piga, Renzo Galanello, Vincenzo De Sanctis, Amal El‐Beshlawy, Alan R. Cohen, Michael Spino, Mohamed Badr, Youssef Al‐Tonbary, Ahmed Mansour and John Connelly. Their work appears in journals such as Blood, American Journal of Hematology, Blood Advances, HemaSphere and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact